Report Detail

Table of Contents

    1 Market Overview

    • 1.1 Market Segment Overview
      • 1.1.1 Product Definition
      • 1.1.2 Market by Type
        • 1.1.2.1 CMX-020
        • 1.1.2.2 CA-016
        • 1.1.2.3 DD-04107
        • 1.1.2.4 Others
      • 1.1.3 Market by Application
        • 1.1.3.1 Ophthalmology
        • 1.1.3.2 Immunology
        • 1.1.3.3 Muscle Spasm
        • 1.1.3.4 Pruritus
        • 1.1.3.5 Abdominal Pain
        • 1.1.3.6 Others
    • 1.2 Global and Regional Market Size
      • 1.2.1 Global Overview
      • 1.2.2 China Overview

    2 Global and Regional Market by Company

    • 2.1 Global
      • 2.1.1 Global Sales by Company
      • 2.1.2 Global Price by Company
    • 2.2 China
      • 2.2.1 China Sales by Company
      • 2.2.2 China Price by Company

    3 Global and Regional Market by Type

    • 3.1 Global
      • 3.1.1 Global Sales by Type
      • 3.1.2 Global Price by Type
    • 3.2 China
      • 3.2.1 China Sales by Type
      • 3.2.2 China Price by Type

    4 Global and Regional Market by Application

    • 4.1 Global
      • 4.1.1 Global Sales by Application
      • 4.1.2 Global Price by Application
    • 4.2 China
      • 4.2.1 China Sales by Application
      • 4.2.2 China Price by Application

    5 Regional Trade

    • 5.1 Export
    • 5.2 Import

    6 Key Manufacturers

    • 6.1 Amgen Inc
      • 6.1.2 Company Information
      • 6.1.2 Product Specifications
      • 6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.2 Amorepacific Corp
      • 6.2.1 Company Information
      • 6.2.2 Product Specifications
      • 6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.3 BCN Peptides SA
      • 6.3.1 Company Information
      • 6.3.2 Product Specifications
      • 6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.4 Centrexion Therapeutics Corp
      • 6.4.1 Company Information
      • 6.4.2 Product Specifications
      • 6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.5 Daewoong Pharmaceutical Co Ltd
      • 6.5.1 Company Information
      • 6.5.2 Product Specifications
      • 6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.6 DoNatur GmbH
      • 6.6.1 Company Information
      • 6.6.2 Product Specifications
      • 6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.7 Flex Pharma Inc
      • 6.7.1 Company Information
      • 6.7.2 Product Specifications
      • 6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.8 Grunenthal GmbH
      • 6.8.1 Company Information
      • 6.8.2 Product Specifications
      • 6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.9 Kyowa Hakko Kirin Co Ltd
      • 6.9.1 Company Information
      • 6.9.2 Product Specifications
      • 6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.10 Medifron DBT Co Ltd
      • 6.10.1 Company Information
      • 6.10.2 Product Specifications
      • 6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.11 Neurim Pharmaceuticals Ltd
    • 6.12 Pila Pharma AB
    • 6.13 Sylentis SAU
    • 6.14 Toray Industries Inc
    • 6.15 Vitality Biopharma Inc

    7 Industry Upstream

    • 7.1 Industry Chain
    • 7.2 Raw Materials

    8 Market Environment

    • 8.1 SWOT
    • 8.2 Porter's Five Forces

    9 Conclusion

    Summary
    Market Segment as follows:
    By Type
    CMX-020
    CA-016
    DD-04107
    Others
    By Application
    Ophthalmology
    Immunology
    Muscle Spasm
    Pruritus
    Abdominal Pain
    Others
    By Company
    Amgen Inc
    Amorepacific Corp
    BCN Peptides SA
    Centrexion Therapeutics Corp
    Daewoong Pharmaceutical Co Ltd
    DoNatur GmbH
    Flex Pharma Inc
    Grunenthal GmbH
    Kyowa Hakko Kirin Co Ltd
    Medifron DBT Co Ltd
    Neurim Pharmaceuticals Ltd
    Pila Pharma AB
    Sylentis SAU
    Toray Industries Inc
    Vitality Biopharma Inc
    The main contents of the report including:
    Section 1:
    Product definition, type and application, global and China market overview;
    Section 2:
    Global and China Market competition by company;
    Section 3:
    Global and China sales revenue, volume and price by type;
    Section 4:
    Global and China sales revenue, volume and price by application;
    Section 5:
    China export and import;
    Section 6:
    Company information, business overview, sales data and product specifications;
    Section 7:
    Industry chain and raw materials;
    Section 8:
    SWOT and Porter's Five Forces;
    Section 9:
    Conclusion.


    Summary:
    Get latest Market Research Reports on Transient Receptor Potential Cation Channel Subfamily V Member 1. Industry analysis & Market Report on Transient Receptor Potential Cation Channel Subfamily V Member 1 is a syndicated market report, published as Global and China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Research by Company, Type & Application 2013-2025. It is complete Research Study and Industry Analysis of Transient Receptor Potential Cation Channel Subfamily V Member 1 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,000.00
    $3,000.00
    $4,000.00
    1,457.17
    2,185.76
    2,914.35
    1,645.40
    2,468.10
    3,290.80
    207,452.00
    311,178.00
    414,904.00
    145,837.60
    218,756.40
    291,675.20
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report